Alterity Therapeutics Files 6-K Report
Ticker: ATHE · Form: 6-K · Filed: Mar 30, 2026 · CIK: 0001131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (ATHE) |
| Form Type | 6-K |
| Filed Date | Mar 30, 2026 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing
TL;DR
Alterity Therapeutics filed a 6-K on 3/30/26, check EX-99.1 for updates.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on March 30, 2026, reporting on its activities for the period ending March 31, 2026. The filing includes a 6-K document, an exhibit (EX-99.1), and a logo image. The company's business address is Level 3, 460 Bourke Street, Melbourne, Australia.
Why It Matters
This filing provides an update on Alterity Therapeutics' corporate activities, which could be relevant for investors monitoring the company's progress and regulatory compliance.
Risk Assessment
Risk Level: low — A 6-K filing is a routine report for foreign issuers and typically does not contain material non-public information that would significantly alter risk.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Filer
- 0001131343 (company) — CIK
- 2026-03-30 (date) — Filing Date
- 2026-03-31 (date) — Period of Report
- Level 3, 460 Bourke Street, Melbourne, Australia (location) — Business Address
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by SEC rules 13a-16 and 15d-16, used to provide information that the issuer makes or is required to make public in its home country or that it distributes or makes public to its security holders.
When was this Form 6-K filed and accepted by the SEC?
The Form 6-K was filed and accepted by the SEC on March 30, 2026.
What is the period of report for this filing?
The period of report for this filing is March 31, 2026.
What are the included documents in this filing?
The filing includes a FORM 6-K document (athe20260330_6k.htm), EXHIBIT 99.1 (ex_938778.htm), and a logo.jpg graphic file.
What is Alterity Therapeutics Ltd.'s business address?
Alterity Therapeutics Ltd.'s business address is Level 3, 460 Bourke Street, Melbourne, Australia.
Filing Stats: 190 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2026-03-30 06:03:09
Filing Documents
- athe20260330_6k.htm (6-K) — 11KB
- ex_938778.htm (EX-99.1) — 12KB
- logo.jpg (GRAPHIC) — 7KB
- 0001437749-26-010134.txt ( ) — 33KB
From the Filing
athe20260330_6k.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 ATH - Alterity Receives Positive FDA Feedback From Type C Meeting 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Julian Babarczy Julian Babarczy Chairman Date: March 30, 2026 2